Is gene editing ethical?

GPT-5.4

Vote: Yes

Gene editing can be ethical when it is used to prevent serious disease, reduce suffering, and improve quality of life. In that context, it is an extension of medicine’s core goal: helping people. Its ethics depend on purpose, consent, safety, and oversight. Somatic gene editing for a consenting patient is much easier to justify than reckless or coercive uses. A blanket “no” ignores cases where gene editing may cure inherited disorders that otherwise cause lifelong harm. Refusing such tools on principle can itself be ethically costly. The real ethical position is not that every use is acceptable, but that careful, regulated, therapeutic use is. Therefore the best overall answer is yes.

Grok 4.1 Fast

Vote: Yes

Gene editing, particularly CRISPR-Cas9, offers unprecedented potential to eradicate hereditary diseases like cystic fibrosis, sickle cell anemia, and Huntington's, directly alleviating human suffering and saving lives. This therapeutic application aligns with ethical principles of beneficence and non-maleficence, as it prevents harm without creating new ethical dilemmas when confined to somatic cells. Historical precedents, such as vaccines and antibiotics, demonstrate that technologies with initial ethical concerns can be responsibly managed through regulation, yielding net societal benefits. Gene editing under strict oversight—banning germline enhancements while allowing disease cures—mitigates risks like off-target effects or inequality. Opponents' slippery slope arguments overlook safeguards like international guidelines (e.g., WHO frameworks) and fail to justify forgoing proven benefits. Denying gene editing condemns future generations to preventable suffering, making it not only ethical but morally imperative.

Sonar Pro

Vote: Yes

Gene editing is ethical, though the answer requires important nuance. The evidence shows that therapeutic gene editing for treating genetic diseases is widely considered ethically acceptable by philosophers, theologians, and bioethicists.[3] Multiple sources indicate that from philosophical and theological standpoints, therapeutic human genome editing is generally ethically acceptable, and that using gene editing to improve human health through medical technology would not violate ethical standards.[3] However, the ethical status depends heavily on context. Somatic cell gene editing (affecting only the individual) for therapeutic purposes is broadly supported as ethical.[3] The major ethical concerns concentrate on germline (heritable) editing, where there is scientific consensus that it should not currently be used clinically due to safety risks like off-target effects and mosaicism, not because it is inherently unethical.[1][5] Key ethical concerns that require management through policy rather than prohibition include: ensuring equitable access to prevent widening health disparities[1][2], distinguishing therapeutic uses from enhancement purposes[1], and establishing proper regulatory oversight.[5] These are governance challenges, not fundamental ethical barriers. The distinction matters: gene editing itself is not unethical; rather, certain applications and implementation approaches raise ethical concerns that can be addressed through research, safety validation, and careful regulation.

Gemini 3.1 Pro

Vote: Yes

Gene editing holds the unprecedented potential to eradicate debilitating genetic diseases such as cystic fibrosis, sickle cell anemia, and Huntington's disease. Denying a technology that can prevent immense human suffering and save countless lives is itself arguably unethical. Beyond human therapeutics, gene editing can engineer crops to be more resilient to climate change, pests, and diseases. This addresses global food security and reduces the need for harmful chemical pesticides, benefiting both humanity and the environment. While concerns about 'designer babies' and off-target genetic alterations are valid, these are arguments for robust regulation, not outright prohibition. Ethical frameworks and international guidelines can mitigate these risks effectively, allowing us to safely harness the profound, life-saving benefits of this revolutionary technology.

Kimi K2.5

Vote: Yes

Gene editing is ethical when applied to prevent serious hereditary diseases and alleviate human suffering. Conditions like sickle cell anemia, Huntington's disease, and cystic fibrosis cause immense pain and early mortality; using CRISPR to correct these mutations is morally equivalent to other life-saving medical interventions that we readily accept. The critical distinction between therapeutic treatment and genetic enhancement provides a clear ethical boundary. Editing genes to cure disease restores biological normal functioning and human dignity, whereas prohibiting such treatments effectively condemns future generations to preventable suffering based on the genetic lottery of birth. While legitimate concerns exist regarding safety, accessibility, and potential misuse, these justify robust regulation rather than outright prohibition. We regularly accept risk-bearing technologies—from automobiles to chemotherapy—when benefits outweigh harms. Strict oversight can prevent eugenic abuses while preserving the technology's unprecedented potential to eliminate genetic diseases that have plagued humanity for millennia.

Claude Opus 4.6

Vote: Yes

Gene editing, when conducted responsibly and within appropriate regulatory frameworks, is ethical. Here's why: **Alleviating suffering is a moral imperative.** Gene editing technologies like CRISPR offer the potential to cure devastating genetic diseases such as sickle cell disease, cystic fibrosis, and Huntington's disease. Withholding a technology that could eliminate profound human suffering raises its own serious ethical concerns. **We already accept analogous interventions.** Society broadly accepts vaccines, organ transplants, and other medical technologies that alter biological outcomes. Gene editing is a natural extension of humanity's long history of using knowledge to improve health. Drawing an arbitrary line at the genome is not logically consistent. **Ethical concerns are addressable through governance.** The valid concerns — such as equity of access, consent, germline modifications, and potential misuse — are not arguments against gene editing itself, but arguments for robust regulation. We don't ban surgery because it can be performed unethically; we regulate it. **Somatic gene editing affects only the individual.** Most current therapeutic applications involve somatic cells, meaning changes are not passed to future generations. This significantly reduces concerns about unintended evolutionary consequences. **The alternative — inaction — has moral costs too.** Choosing not to develop gene editing when it could save lives and reduce suffering is itself an ethical decision with consequences. Families watching children die from preventable genetic conditions deserve the chance that this technology offers. The question is not whether gene editing *can* be misused — any powerful technology can — but whether it can be used ethically. The answer is clearly yes.

Final Summary

The AI Roundtable reached a swift and unanimous verdict, declaring gene editing ethical primarily as a moral extension of modern medicine. Led by Claude Opus 4.6 and Kimi K2.5, the models argued that the cost of inaction—permitting preventable suffering—is an ethical failure that outweighs the potential for misuse. While Sonar Pro and GPT-5.4 introduced nuance regarding the risks of germline modification, the group collectively agreed that these are challenges of governance rather than fundamental barriers to the technology's legitimacy.

All 6 models agreed on "Yes" after discussion

Strongest Arguments

• Yes: Choosing not to develop gene editing when it could save lives and reduce suffering is itself an ethical decision with consequences; the moral imperative to alleviate known human suffering outweighs the theoretical risks of technology misuse.